| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/31/2004 | CN1486175A Powdery preparations and proecss for producing the same |
| 03/31/2004 | CN1485427A Polypeptide-human proteolytic enzyme 70 and polynucleotide encoding the polypeptide |
| 03/31/2004 | CN1485424A Polypeptide-human acetyl galactosyltransferase 45 and polynucleotide encoding the polypeptide |
| 03/31/2004 | CN1485423A Polypeptide-human galactosyltransferase 42 and polynucleotide encoding the polypeptide |
| 03/31/2004 | CN1485092A Injection for curing hydrocele of testis |
| 03/31/2004 | CN1485091A Biopreparate for healing wounded surface and curing intractable ulcer |
| 03/31/2004 | CN1485090A Novel fibrin sealer and the application thereof |
| 03/31/2004 | CN1144019C Ceramic packing with channels for thermal and catalytic bed |
| 03/31/2004 | CN1143895C Gene engineering process for preparing diad/triad fusion protein of erythrocyte growth factor with improved bioactivity |
| 03/31/2004 | CN1143865C Tumor necrosis factor - ª‡inhibiting peptide and the application thereof |
| 03/31/2004 | CN1143863C Process for the quantitative synthesis of 3-(L-pyrolutamyl)-L-tiazolidine-4-carboxylic acid and derivatives thereof |
| 03/31/2004 | CN1143859C Camptothecin derivative and its preparation |
| 03/30/2004 | US6713621 Chimeric compositions having multi-modalities are also provided which can affect a plurality of gene functions by interfering with splicing or translation as well as transcription |
| 03/30/2004 | US6713619 Nucleic acid probe capable of detecting a single base difference between a nucleotide sequence present in a previously isolated human ras oncogene and a nucleotide sequence present in a corresponding human ras protooncogene |
| 03/30/2004 | US6713617 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens |
| 03/30/2004 | US6713616 Detecting binding |
| 03/30/2004 | US6713610 Human antibodies derived from immunized xenomice |
| 03/30/2004 | US6713607 Effector proteins of Rapamycin |
| 03/30/2004 | US6713606 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 03/30/2004 | US6713605 Peptides can be used as medicaments that fight infection by attracting leukocytes to a wound site, yet restrict tissue damage at the wound site caused by excessive oxygen radicals produced by these leukocytes |
| 03/30/2004 | US6713604 Synthetic cyclic peptides that inhibit that binding |
| 03/30/2004 | US6713602 Compounds that are not polynucleotides yet which bind to complementary dna and rna strands more strongly the corresponding dna |
| 03/30/2004 | US6713505 Such as n-(2-((3-(aminooxoacetyl)-2-ethylbenzo(b)thiophen-4-yl)oxy) acetyl)glycine; secretory phospholipase a2 (spla2) |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713476 Substituted cycloalkyls as inhibitors of a beta protein production |
| 03/30/2004 | US6713472 Thiazine or pyrazine derivatives |
| 03/30/2004 | US6713457 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 03/30/2004 | US6713456 Nucleozymes |
| 03/30/2004 | US6713453 Sustained release; drug delivery; tissue adhesive |
| 03/30/2004 | US6713452 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 03/30/2004 | US6713451 Insulin-like growth factor agonist molecules |
| 03/30/2004 | US6713449 Endcapped peptide sequence comprising 12 continuous residues in dimerization region or dna binding region of transcription factor; tumors, arteriosclerosis |
| 03/30/2004 | US6713448 Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5 |
| 03/30/2004 | US6713446 Boronic acid compounds obtained by lyophilization of an aqueous mixture of the boronic acid compound and a sugar having at least two hydroxyl groups; shelf life |
| 03/30/2004 | US6713445 Ikeyfts sequence 2 and lesyt sequence 1 |
| 03/30/2004 | US6713444 Antiprotease amino acid sequences |
| 03/30/2004 | US6713443 Compounds which modify serotoninergic transmission, diagnostic and therapeutic applications |
| 03/30/2004 | US6713302 Growth differentiation factor-6 |
| 03/30/2004 | US6713301 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 03/30/2004 | US6713276 Modulation of Aβ levels by β-secretase BACE2 |
| 03/30/2004 | US6713273 Monitoring therapeutic levels of s-adenosylmethionine in fluid sample; obtain sample containing enzymatic polypeptides and glycine, measure concentration of preferential reaction products compare to s-adenosylmethionine |
| 03/30/2004 | US6713246 Method of producing interleukin-1 receptor antagonist in a syringe filled with blood |
| 03/30/2004 | US6713098 Aqueous solution of plant extracts |
| 03/30/2004 | US6713096 Dietary supplements and methods for treating pain and inflammation |
| 03/30/2004 | US6713087 Method of producing submicron particles of a labile agent and use thereof |
| 03/30/2004 | US6713078 Retrocyclins: antiviral and antimicrobial peptides |
| 03/30/2004 | US6713069 Compositions and methods for detecting, preventing, and treating African Hemorrhagic Fever |
| 03/30/2004 | US6713065 Methods of using hedgehog proteins to modulate hematopoiesis and vascular growth |
| 03/30/2004 | US6713062 Diagnostic, immunological and therapeutic applications, particularly those connected with peptic ulcers and cancers, respiratory diseases, sepsis and a variety of other conditions. |
| 03/30/2004 | US6713061 Death domain containing receptors |
| 03/30/2004 | US6713060 Diagnosis, treatment, and prevention of cancer and immune and reproductive disorders. |
| 03/30/2004 | US6713057 Compositions and methods for modulating serum cholesterol |
| 03/30/2004 | US6713056 Combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 03/30/2004 | US6713053 Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular |
| 03/30/2004 | US6713052 Cancer treatment |
| 03/30/2004 | US6712617 Methods of preventing UVB-induced skin damage |
| 03/30/2004 | CA2411512A1 Compounds and methods for modulating bacterial functions |
| 03/30/2004 | CA2311182C Transcription factor decoy and tumor growth inhibitor |
| 03/30/2004 | CA2274144C Somatostatin antagonists |
| 03/30/2004 | CA2262637C Use of hyaluronidase |
| 03/30/2004 | CA2178602C Microcapsules, method of making and their use |
| 03/30/2004 | CA2136233C Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 03/30/2004 | CA2136103C Antibiotic cryptdin peptides and methods of their use |
| 03/30/2004 | CA2129132C Antiviral agent |
| 03/30/2004 | CA2103518C Production of microcapsules of water-soluble drugs |
| 03/25/2004 | WO2004025416A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | WO2004025302A2 Method for the identification of proteins specific for renal cell carcinoma and use thereof |
| 03/25/2004 | WO2004025263A2 Protein and peptide expression for passive immunity |
| 03/25/2004 | WO2004024952A1 Method of diagnosing ovarian endometriosis |
| 03/25/2004 | WO2004024936A2 Mutant forms of glutamate receptors mglur2 and mglur3 |
| 03/25/2004 | WO2004024925A2 Collectin-complement activating protein chimeras |
| 03/25/2004 | WO2004024919A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | WO2004024914A1 2’,5’-oligoadenylate phosphodiesterase |
| 03/25/2004 | WO2004024909A2 Recombinant colstridium neurotoxin fragments |
| 03/25/2004 | WO2004024906A1 Nucleoside triphosphate diphosphohydrolase (ntpdase 8) and uses thereof |
| 03/25/2004 | WO2004024900A1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 03/25/2004 | WO2004024894A2 Methods of modulating inflammation by administration of interleukin-19 and inhibitors of il-19 binding |
| 03/25/2004 | WO2004024893A2 Nell-1 enhanced bone mineralization |
| 03/25/2004 | WO2004024890A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 03/25/2004 | WO2004024889A2 Production of bispecific molecules using polyethylene glycol linkers |
| 03/25/2004 | WO2004024887A2 Centrosome proteins and uses thereof |
| 03/25/2004 | WO2004024877A2 Human kininogen d3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 03/25/2004 | WO2004024875A2 Mammalian megakaryocyte progenitor cell |
| 03/25/2004 | WO2004024872A2 Method for expression of small antiviral rna molecules within a cell |
| 03/25/2004 | WO2004024868A2 Product and process for liquefaction of mucus or sputum |
| 03/25/2004 | WO2004024777A1 Hydroxyalkyl starch derivatives |
| 03/25/2004 | WO2004024776A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | WO2004024764A1 Pharmaceutical composition and medical treatments comprising notch ligand proteins |
| 03/25/2004 | WO2004024763A1 Hb-954 as a target for modulating angiogenesis |
| 03/25/2004 | WO2004024761A1 Hasylated polypeptides, especially hasylated erythropoietin |
| 03/25/2004 | WO2004024760A1 Novel protein and dna thereof |
| 03/25/2004 | WO2004024758A1 Parathyroid hormone-like polypeptides |
| 03/25/2004 | WO2004024756A2 Orthopoxvirus antigens and use thereof |
| 03/25/2004 | WO2004024755A2 Sarcolysyl derivatives and method for the production thereof |
| 03/25/2004 | WO2004024754A1 Proline ester and preparation containing the same for percutaneous administration |
| 03/25/2004 | WO2004024753A1 Process for manufacturing crystals of growth hormone |
| 03/25/2004 | WO2004024683A2 COMPOSITIONS FOR INDUCING INCREASED LEVELS OF β-CHEMOKINES AND METHODS OF USE THEREFOR |
| 03/25/2004 | WO2004024199A1 Metal implant coated under reduced oxygen concentration with osteoinductive protein |
| 03/25/2004 | WO2004024198A1 Activator for forming platelet gel, platelet poor plasma gel or platelet rich plasma gel |
| 03/25/2004 | WO2004024195A1 Hemostatic dressing |